Literature DB >> 11741219

Maturation and growth of renal function: dosing renally cleared drugs in children.

W L Hayton1.   

Abstract

A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (QR). Published RFP values were obtained from 63 healthy children between the ages of 2 days and 12 years. Maturation over time was assumed to be exponential from an immature (RFP(im)) to a mature (RFP(ma)) level; for growth, RFP(im) and RFP(ma) were assumed to follow the allometric equation: RFP (age, W) = aW(b)e(-kmat*age)+ cWb(1- e(-kmat*age)), where W is body weight, k(mat) is the maturation rate constant, b is the body weight exponent, and a and c are RFP(im) and RFP(ma) at unit W. The model-based equation was fitted to the age-W, RFP values by a nonlinear least-squares method. For GF, the maturation half-life was 7.9 months (90% maturation, 26 months), the body weight exponent was 0.662, and the ratio c/a (which reflected the magnitude of the maturation influence) was 3.1. For AS and QR, the maturation half-lives were about 3.8 months and the ratio c/a was about 1.8. For renally eliminated drugs, the model can be used to estimate dosing regimens that are based on the adult dosing regimen and the age and weight of the child.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11741219      PMCID: PMC2750998          DOI: 10.1208/ps020103

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  8 in total

1.  MATURATION OF RENAL FUNCTION IN CHILDHOOD: CLEARANCE STUDIES.

Authors:  M I Rubin; E Bruck; M Rapoport; M Snively; H McKay; A Baumler
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

Review 2.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

3.  Should clearance be normalised to body surface or to lean body mass?

Authors:  T H Hallynck; H H Soep; J A Thomis; J Boelaert; R Daneels; L Dettli
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

Review 4.  Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.

Authors:  B J Anderson; A D McKee; N H Holford
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  Expressing glomerular filtration rate in children.

Authors:  D C Heilbron; M A Holliday; A al-Dahwi; B A Kogan
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants.

Authors:  W L Hayton; J Kneer; R de Groot; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

7.  Status of drug approval processes and regulation of medications for children.

Authors:  R E Kauffman
Journal:  Curr Opin Pediatr       Date:  1995-04       Impact factor: 2.856

Review 8.  Pharmacokinetics in the child.

Authors:  W R Crom
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  8 in total
  59 in total

1.  Allometric scaling of xenobiotic clearance: uncertainty versus universality.

Authors:  T M Hu; W L Hayton
Journal:  AAPS PharmSci       Date:  2001

2.  A simple height-independent equation for estimating glomerular filtration rate in children.

Authors:  Hans Pottel; Liesbeth Hoste; Frank Martens
Journal:  Pediatr Nephrol       Date:  2012-01-18       Impact factor: 3.714

3.  Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.

Authors:  Feng Yang; Xianping Tong; D Gail McCarver; Ronald N Hines; Daniel A Beard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-07       Impact factor: 2.745

4.  Different pharmacokinetics of tramadol in mothers treated for labour pain and in their neonates. Towards an increased knowledge of paediatric clinical pharmacology.

Authors:  Trevor N Johnson
Journal:  Eur J Clin Pharmacol       Date:  2005-10-26       Impact factor: 2.953

Review 5.  The interplay between drugs and the kidney in premature neonates.

Authors:  Michiel F Schreuder; Ruud R G Bueters; Karel Allegaert
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

6.  Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children.

Authors:  Céline Thibault; Jean Lavigne; Catherine Litalien; Nastya Kassir; Yves Théorêt; Julie Autmizguine
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

7.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 8.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

Review 9.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

Review 10.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.